Stay Tuned to the LDL Controversy

March 2017

Debate continues about the role of LDL levels in statin patients.

We know the new thinking is to use target DOSES of statins to reduce CV risk...instead of titrating to a specific LDL goal.

But don't recommend a "fire and forget" approach.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote